SonoThera, a biotechnology company dedicated to treating the root cause of human diseases through genetic therapy, announced completion of its $60.75M Series A financing round.

Lead investor ARCH Venture Partners was joined by investors Illumina Ventures, Johnson & Johnson Innovation - JJDC, Inc., Vertex Ventures HC, and Medical Excellence Capital. Also participating in this financing round were Eli Lilly & Company, Alexandria Venture Investments, Lifespan Investments, Formic Ventures, Foothill Ventures, and Wilson Sonsini.